Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. It operates in two segments, Domestic and International. The company's products include steel, wood, laminate furniture, fume hoods, biological safety cabinets, laminar flow and ductless hoods, adaptable modular and column systems, moveable workstations and carts, epoxy resin worksurfaces, sinks, and accessories and related design services. Its laboratory products are used in chemistry, physics, biology, and other general science laboratories in the pharmaceutical, biotechnology, industrial, chemical, commercial, educational, government, and health care markets; technical products are used in facilities manufacturing computers and light electronics and by users of computer and networking furniture; and laminate caseworks that are used in educational, healthcare, and industrial applications. The company sells its products primarily through dealers, commissioned agents, and a national distributor, as well as through competitive bids submitted by the company and its subsidiaries in Singapore, India, and China. Kewaunee Scientific Corporation was founded in 1906 and is headquartered in Statesville, North Carolina.
IPO Year:
Exchange: NASDAQ
Website: kewaunee.com
| Date | Price Target | Rating | Analyst |
|---|
Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.
4 - KEWAUNEE SCIENTIFIC CORP /DE/ (0000055529) (Issuer)
4 - KEWAUNEE SCIENTIFIC CORP /DE/ (0000055529) (Issuer)
4 - KEWAUNEE SCIENTIFIC CORP /DE/ (0000055529) (Issuer)
4 - KEWAUNEE SCIENTIFIC CORP /DE/ (0000055529) (Issuer)
10-Q - KEWAUNEE SCIENTIFIC CORP /DE/ (0000055529) (Filer)
8-K - KEWAUNEE SCIENTIFIC CORP /DE/ (0000055529) (Filer)
8-K - KEWAUNEE SCIENTIFIC CORP /DE/ (0000055529) (Filer)
8-K - KEWAUNEE SCIENTIFIC CORP /DE/ (0000055529) (Filer)
144 - KEWAUNEE SCIENTIFIC CORP /DE/ (0000055529) (Subject)
10-Q - KEWAUNEE SCIENTIFIC CORP /DE/ (0000055529) (Filer)
8-K - KEWAUNEE SCIENTIFIC CORP /DE/ (0000055529) (Filer)
8-K - KEWAUNEE SCIENTIFIC CORP /DE/ (0000055529) (Filer)
8-K - KEWAUNEE SCIENTIFIC CORP /DE/ (0000055529) (Filer)
8-K - KEWAUNEE SCIENTIFIC CORP /DE/ (0000055529) (Filer)
Fastest customizable press release news feed in the world
STATESVILLE, N.C., Dec. 10, 2025 /PRNewswire/ -- Kewaunee Scientific Corporation (NASDAQ:KEQU) today announced results for its second quarter ended October 31, 2025. Fiscal Year 2026 Second Quarter Results: Sales during the second quarter of fiscal year 2026 were $70,096,000, an increase of 46.8% compared to sales of $47,764,000 from the prior year's second quarter. Pre-tax earnings for the quarter were $3,453,000 compared to $3,931,000 for the prior year quarter, a decrease of 12.2%. Net earnings were $2,445,000 compared to net earnings of $3,008,000 for the prior year quarte
STATESVILLE, N.C., Dec. 4, 2025 /PRNewswire/ -- Kewaunee Scientific Corporation (NASDAQ:KEQU), a recognized leader in the design, manufacture, and installation of laboratory, healthcare, and technical furniture products, today announced its successful debt refinancing and the full repayment of its Seller Notes. On December 4, 2025, Kewaunee Scientific Corporation (the "Company" or "Kewaunee") successfully repaid in full and ahead of schedule its Seller Notes, entered into November 1, 2024, in connection with the Company's acquisition of Nu Aire, Inc. ("Nu Aire"). The Seller No
STATESVILLE, N.C., Nov. 26, 2025 /PRNewswire/ -- Kewaunee Scientific Corporation (NASDAQ:KEQU) today announced that the Company plans to release its second quarter fiscal year 2026 financial results on Wednesday, December 10, 2025 after the close of trading. This information will be available on the Company's website www.kewaunee.com after the release. About Kewaunee Scientific Founded in 1906, Kewaunee Scientific Corporation is a recognized global leader in the design, manufacture, and installation of laboratory, healthcare, and technical furniture products. The Company's pr
STATESVILLE, N.C., Sept. 11, 2025 /PRNewswire/ -- Kewaunee Scientific Corporation (NASDAQ:KEQU), a recognized leader in the design, manufacture, and installation of laboratory, healthcare, and technical furniture products, announces the appointment of J. Jette Campbell, CPA, to its Board of Directors, effective September 10, 2025. Campbell brings decades of experience guiding organizations through significant growth and transformation. Campbell's impressive career spans leadership roles at global companies such as PepsiCo, Frito-Lay, and Griffin LLC, a DuPont venture. He also
STATESVILLE, N.C., Sept. 10, 2025 /PRNewswire/ -- PRNewswire / Kewaunee Scientific Corporation (NASDAQ:KEQU) today announced results for its first quarter ended July 31, 2025. Fiscal Year 2026 First Quarter Results: Sales during the first quarter of fiscal year 2026 were $71,104,000, an increase of 46.9% compared to sales of $48,393,000 from the prior year's first quarter. Pre-tax earnings for the quarter were $3,920,000 compared to $2,430,000 for the prior year quarter, an increase of 61.3%. Net earnings were $3,093,000 compared to net earnings of $2,193,000 for the prior yea
STATESVILLE, N.C., Sept. 2, 2025 /PRNewswire/ -- Kewaunee Scientific Corporation (NASDAQ:KEQU) today announced that the Company will attend the 2025 Arablab Live tradeshow and conference, taking place in Dubai from September 23-25. This year, attendees can look forward to product demonstrations and the opportunity to connect with representatives from Kewaunee's corporate and international teams, newly acquired containment and biosafety powerhouse NuAire, and the Company's healthcare brand EVERHUTCH. The Company will also share market insights from its research partner Koncepo.
STATESVILLE, N.C., Aug. 27, 2025 /PRNewswire/ -- Kewaunee Scientific Corporation (NASDAQ:KEQU) today announced that the Company plans to release its first quarter fiscal year 2026 financial results on Wednesday, September 10, 2025 after the close of trading. This information will be available on the Company's website www.kewaunee.com after the release. About Kewaunee Scientific Founded in 1906, Kewaunee Scientific Corporation is a recognized global leader in the design, manufacture, and installation of laboratory, healthcare, and technical furniture products. The Company's pr
STATESVILLE, N.C., June 25, 2025 /PRNewswire/ -- Kewaunee Scientific Corporation (NASDAQ:KEQU) today announced results for its fourth quarter and its fiscal year ended April 30, 2025. Fiscal Year 2025 Fourth Quarter Results Sales during the fourth quarter of fiscal year 2025 were $77,148,000, an increase of 36.1% compared to sales of $56,702,000 from the prior year's fourth quarter. Pre-tax earnings for the quarter were $7,149,000 compared to $1,347,000 for the prior year quarter. Net earnings for the quarter were $4,850,000 compared to net earnings of $11,026,000 for the prio
STATESVILLE, N.C., June 11, 2025 /PRNewswire/ -- Kewaunee Scientific Corporation (NASDAQ:KEQU) today announced that the Company plans to release financial results for its fourth quarter and fiscal year ended April 30, 2025 on Wednesday, June 25, 2025 after the close of trading. This information will be available on the Company's website www.kewaunee.com after the release. About Kewaunee Scientific Founded in 1906, Kewaunee Scientific Corporation is a recognized global leader in the design, manufacture, and installation of laboratory, healthcare, and technical furniture produc
STATESVILLE, N.C., March 12, 2025 /PRNewswire/ -- Kewaunee Scientific Corporation (NASDAQ:KEQU) today announced an amendment to its existing share repurchase program. On March 12, 2025, the Board of Directors of Kewaunee Scientific Corporation (the "Company") amended its existing share repurchase program initially approved on August 31, 2023, and in effect September 1, 2023. The Board of Directors authorized the repurchase of up to an additional 100,000 shares of the Company's common stock under the existing share repurchase program, as amended (the "Program"), which does not
Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.
4 - KEWAUNEE SCIENTIFIC CORP /DE/ (0000055529) (Issuer)
4 - KEWAUNEE SCIENTIFIC CORP /DE/ (0000055529) (Issuer)
4 - KEWAUNEE SCIENTIFIC CORP /DE/ (0000055529) (Issuer)
4 - KEWAUNEE SCIENTIFIC CORP /DE/ (0000055529) (Issuer)
4 - KEWAUNEE SCIENTIFIC CORP /DE/ (0000055529) (Issuer)
4 - KEWAUNEE SCIENTIFIC CORP /DE/ (0000055529) (Issuer)
4 - KEWAUNEE SCIENTIFIC CORP /DE/ (0000055529) (Issuer)
3 - KEWAUNEE SCIENTIFIC CORP /DE/ (0000055529) (Issuer)
4 - KEWAUNEE SCIENTIFIC CORP /DE/ (0000055529) (Issuer)
4 - KEWAUNEE SCIENTIFIC CORP /DE/ (0000055529) (Issuer)
Live Leadership Updates
STATESVILLE, N.C., Sept. 11, 2025 /PRNewswire/ -- Kewaunee Scientific Corporation (NASDAQ:KEQU), a recognized leader in the design, manufacture, and installation of laboratory, healthcare, and technical furniture products, announces the appointment of J. Jette Campbell, CPA, to its Board of Directors, effective September 10, 2025. Campbell brings decades of experience guiding organizations through significant growth and transformation. Campbell's impressive career spans leadership roles at global companies such as PepsiCo, Frito-Lay, and Griffin LLC, a DuPont venture. He also
Live finance-specific insights
STATESVILLE, N.C., June 25, 2025 /PRNewswire/ -- Kewaunee Scientific Corporation (NASDAQ:KEQU) today announced results for its fourth quarter and its fiscal year ended April 30, 2025. Fiscal Year 2025 Fourth Quarter Results Sales during the fourth quarter of fiscal year 2025 were $77,148,000, an increase of 36.1% compared to sales of $56,702,000 from the prior year's fourth quarter. Pre-tax earnings for the quarter were $7,149,000 compared to $1,347,000 for the prior year quarter. Net earnings for the quarter were $4,850,000 compared to net earnings of $11,026,000 for the prio
STATESVILLE, N.C., March 12, 2025 /PRNewswire/ -- Kewaunee Scientific Corporation (NASDAQ:KEQU) today announced results for its third quarter ended January 31, 2025. Fiscal Year 2025 Third Quarter Results: Sales during the third quarter of fiscal year 2025 were $67,167,000, an increase of 43.6% compared to sales of $46,778,000 from the prior year's third quarter. Pre-tax earnings for the quarter were $1,275,000 compared to $3,515,000 for the prior year quarter, a decrease of 63.7%. Net earnings were $1,354,000 compared to net earnings of $2,521,000 for the prior year quarter.
STATESVILLE, N.C., Dec. 11, 2024 /PRNewswire/ -- Kewaunee Scientific Corporation (NASDAQ:KEQU) today announced results for its second quarter ended October 31, 2024. Fiscal Year 2025 Second Quarter Results: Sales during the second quarter of fiscal year 2025 were $47,764,000, a decrease of 5.3% compared to sales of $50,436,000 from the prior year's second quarter. Pre-tax earnings for the quarter were $3,931,000 compared to $4,845,000 for the prior year quarter, a decrease of 18.9%. Net earnings were $3,008,000 compared to net earnings of $2,732,000 for the prior year quarter.
This live feed shows all institutional transactions in real time.
SC 13G/A - KEWAUNEE SCIENTIFIC CORP /DE/ (0000055529) (Subject)
SC 13G/A - KEWAUNEE SCIENTIFIC CORP /DE/ (0000055529) (Subject)
SC 13G/A - KEWAUNEE SCIENTIFIC CORP /DE/ (0000055529) (Subject)
SC 13D/A - KEWAUNEE SCIENTIFIC CORP /DE/ (0000055529) (Subject)
SC 13G/A - KEWAUNEE SCIENTIFIC CORP /DE/ (0000055529) (Subject)
SC 13D/A - KEWAUNEE SCIENTIFIC CORP /DE/ (0000055529) (Subject)
SC 13G/A - KEWAUNEE SCIENTIFIC CORP /DE/ (0000055529) (Subject)
SC 13G/A - KEWAUNEE SCIENTIFIC CORP /DE/ (0000055529) (Subject)
SC 13D - KEWAUNEE SCIENTIFIC CORP /DE/ (0000055529) (Subject)
SC 13G - KEWAUNEE SCIENTIFIC CORP /DE/ (0000055529) (Subject)